Arsov C, Albers P
Klinik für Urologie der Heinrich Heine Universität Düsseldorf.
Aktuelle Urol. 2009 Mar;40(2):87-90. doi: 10.1055/s-0028-1098851. Epub 2009 Mar 18.
In Germany, ambitious efforts for the implementation of well-defined quality standards in the diagnosis of and therapy for prostate cancer have resulted in the creation of certified centres over the past years. This development is in analogy to that of certified breast and intestinal centres. Concerning the prostate, there are two different models for the certification of centres. The model of the Dachverband der Prostatazentren e. V. (DVPZ) includes the most common kinds of dis-eases of the prostate, namely BPH, prostate cancer and prostatitis. On the other hand prostate cancer centres are certified by the Deutsche Krebsgesellschaft (DKG). Among German urologists there is a controversial discussion concerning this process. The present paper gives a review of the two models and discusses the chances as well as the risks which come along with certified centres.
在德国，过去几年里为在前列腺癌的诊断和治疗中实施明确的质量标准所做的积极努力催生了认证中心。这一发展与认证乳腺和肠道中心的情况类似。就前列腺而言，有两种不同的中心认证模式。德国前列腺中心协会（DVPZ）的模式涵盖了前列腺最常见的疾病类型，即良性前列腺增生（BPH）、前列腺癌和前列腺炎。另一方面，前列腺癌中心由德国癌症协会（DKG）认证。在德国泌尿科医生中，关于这一过程存在争议性的讨论。本文对这两种模式进行了综述，并讨论了认证中心带来的机遇和风险。
